Edition:
India

Concert Pharmaceuticals Q2 Loss Per Share $0.78


Thursday, 1 Aug 2019 

Aug 1 (Reuters) - Concert Pharmaceuticals Inc ::CONCERT PHARMACEUTICALS REPORTS SECOND QUARTER 2019 FINANCIAL RESULTS AND PROVIDES COMPANY UPDATE.Q2 LOSS PER SHARE $0.78.Q2 EARNINGS PER SHARE ESTIMATE $-0.89 -- REFINITIV IBES DATA.CASH, CASH EQUIVALENTS AND INVESTMENTS AS OF JUNE 30, 2019, TOTALED $136.6 MILLION.CONCERT PHARMACEUTICALS - EXPECTS CASH, CASH EQUIVALENTS AND INVESTMENTS TO BE SUFFICIENT TO FUND COMPANY INTO SECOND HALF OF 2020. 

Related Company News

Company Quote

10.87
-0.17 -1.54%
14 Feb 2020